
News
Contact Us

Australia Allows Umbilical Cord Blood Therapy for Cerebral Palsy
Parent’s Guide to Cord Blood, June 2025 Zara was the first child in Australia to receive cord blood therapy for cerebral palsy outside of a

New stem cell therapy to treat patients with blood cancers
EMA, 20 June 2025 Zemcelpro provides an option for patients with blood cancer who need a blood stem cell transplant and have no suitable donor

Optimized Gmp-Grade Wharton’s Jelly’s Mesenchymal Stromal Cells Manufacturing and Administration Protocol for Graft Versus Host Disease Prevention
SSRN, 20 May 2025 Mesenchymal stromal cells derived from Wharton’s jelly (WJ-MSCs) are multipotent cells originating from the umbilical cord, possessing strong immunomodulatory properties. These

Pooling umbilical cord-mesenchymal stromal cells derived from selected multiple donors reduces donor-dependent variability and improves their immunomodulatory properties
Stem Cell Research & Therapy, 20/05/2025 A groundbreaking study published by Miryam Mebarki and colleagues in the journal Stem Cell Research & Therapy has demonstrated

hUC-MSCs loaded collagen scaffold for refractory thin endometrium caused by Asherman syndrome: a double-blind randomized controlled trial
Pubmed Central, May 15, 2025 A double-blind randomized clinical trial conducted by Zhaojuan Hou and colleagues at Xiangya Hospital, Central South University, evaluated the efficacy

How Can the Placenta Help Us Understand Cancer?
The Scientist, May 14, 2025 Like cancer, placental cells multiply rapidly, invade tissues, and evade destruction by the immune system, but maternal biology somehow keeps

Neonatal factors impacting umbilical cord blood unit characteristics
Nature, May 14, 2025 A study published in Scientific Reports by Nature (2025) has shed light on the role of neonatal factors in determining the

Cell therapy with placenta-derived mesenchymal stem cells for secondary progressive multiple sclerosis patients in a phase 1 clinical trial
Nature, 08/05/2025 A phase 1 clinical trial conducted by researchers at Tehran University of Medical Sciences evaluated the safety and feasibility of placenta-derived mesenchymal stem

Successful treatment of very severe aplastic anemia with double unrelated umbilical cord blood transplantation in a donor-specific antigen positive adult patient: A case report and review
ScienceDirect, May 2025 A recent study published in Transplant Immunology (2025) reported the successful treatment of an adult patient with very severe aplastic anemia (VSAA)

Novel method enables safe delivery of stem cells in critically ill patients on external lung support
Medical Xpress, April 16 2025 Mesenchymal stromal cells (MSCs) are delivered directly into the lungs using a bronchoscope (CIBA method), where they migrate through the